About Sophim
Sophim is a company based in Peyruis (France) founded in 1988. Sophim has raised $22.29 million across 2 funding rounds from investors including M Capital. Sophim has completed 1 acquisition, including Novastell. Sophim operates in a competitive market with competitors including Insempra, Vytrus Biotech, Naturex, Beraca Natural Ingredients and Mibelle Biochemistry, among others.
- Headquarter Peyruis, France
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sophim
Sophim has successfully raised a total of $22.29M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $21.06 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sophim
Sophim has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include M Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment solutions are provided by M Capital for various sectors.
|
Locked | Locked | Locked |
Investor details for Sophim
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sophim
Sophim has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Novastell.
Investment portfolio details for Sophim
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Plant-based medicines are manufactured by Novastell in the healthcare sector.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Sophim
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sophim
Detailed financials for Sophim
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sophim Comparisons
Peer comparison for Sophim
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sophim
Sophim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insempra, Vytrus Biotech, Naturex, Beraca Natural Ingredients and Mibelle Biochemistry, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sustainable ingredients and materials for biotechnology are manufactured.
|
|
| Locked | Locked | Locked |
Plant-based active ingredients for cosmetics are developed by the company.
|
|
| Locked | Locked | Locked |
Natural extracts are manufactured for colorings, flavorings, and nutraceuticals.
|
|
| Locked | Locked | Locked |
Organic natural ingredients are retailed by Beraca from Brazil.
|
|
| Locked | Locked | Locked |
Provides innovative active ingredients for cosmetics and food health sectors globally.
|
Detailed competitors of Sophim
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sophim
Complete news archive for Sophim
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sophim
Sophim was founded in 1988 and raised its 1st funding round 24 years after it was founded.
Sophim is headquartered in Peyruis, France. It is registered at Peyruis, Alpes-de-haute-provence, France.
Jacques Margnat is the current CEO of Sophim.
Sophim is a funded company, having raised a total of $22.29M across 2 funding rounds to date.
Founded in 1988 and based in Peyruis, France, operations focus on the production of squalane-derived ingredients for the cosmetics, pharmaceutical, and veterinary sectors. The product range encompasses waxes, butters, oils, and hydrogenated polyisobutene, all sourced from vegetable extracts. These materials are utilized in various applications, supporting formulations in medicines and personal care items across international markets.
Sophim's top competitors include Insempra, Vytrus Biotech and Naturex.
Sophim has made 1 acquisition, including Novastell.
Sophim has 1 investor. Key investors include M Capital.